Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine
Nerivio Wearable Migraine Therapeutic Now Eligible for Coverage through UpScript’s Telemedicine Platform